PubMed

Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies.

Hamacher T, Schinzel M, Schölzel-Klatt A, Neff HM, Maier H, Schlaffer G, Beausencourt E, Jütte M, Scholz R, Lorger C, Stewart WC.

Br J Ophthalmol. 2004 Oct;88(10):1295-8.PMID: 15377554 [PubMed - indexed for MEDLINE]Related articlesFree article

Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapies.

Konstas AG, Bányai L, Blask KD, Väth J, Kozobolis VP, Trüb PR, Tsironi S, Maloutas S, Teus MA, Stewart WC.

J Ocul Pharmacol Ther. 2004 Oct;20(5):375-82.PMID: 15650512 [PubMed - indexed for MEDLINE]Related articles

Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies.

Bayer A, Weiler W, Oeverhaus U, Skrotzki FE, Stewart WC; Xplore Observation Group.

J Ocul Pharmacol Ther. 2004 Dec;20(6):470-8.PMID: 15684807 [PubMed - indexed for MEDLINE]Related articles

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.PMID: 12795627 [PubMed - indexed for MEDLINE]Related articles

Intraocular pressure, safety and quality of life in glaucoma patients switching to latanoprost from adjunctive and monotherapy treatments.

Haverkamp F, Wuensch S, Fuchs M, Stewart WC.

Eur J Ophthalmol. 2004 Sep-Oct;14(5):407-15.PMID: 15506603 [PubMed - indexed for MEDLINE]Related articles

Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.

Konstas AG, Mikropoulos D, Dimopoulos AT, Moumtzis G, Nelson LA, Stewart WC.

Br J Ophthalmol. 2008 Nov;92(11):1498-502. Epub 2008 Aug 14.PMID: 18703549 [PubMed - indexed for MEDLINE]Related articles

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

Am J Ophthalmol. 2001 Oct;132(4):472-84.PMID: 11589866 [PubMed - indexed for MEDLINE]Related articles

Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.

Simmons ST, Samuelson TW.

Clin Ther. 2000 Apr;22(4):388-99.PMID: 10823361 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.

Stewart WC, Stewart JA, Day DG, Sharpe ED, Jenkins JN.

Eye (Lond). 2004 Oct;18(10):990-5.PMID: 15037890 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR.

Ann Pharmacother. 2008 Apr;42(4):498-504. Epub 2008 Mar 25.PMID: 18364402 [PubMed - indexed for MEDLINE]Related articles

Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.

Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A, Viswanathan A, Vorwerk C, Goldblum D.

Ophthalmology. 2007 Dec;114(12):2244-51. Epub 2007 Apr 25.PMID: 17459480 [PubMed - indexed for MEDLINE]Related articles

Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.

Susanna R Jr, Sheu WP; Latin American Glaucoma Society.

Clin Ther. 2004 May;26(5):755-68.PMID: 15220019 [PubMed - indexed for MEDLINE]Related articles

Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.

Cvenkel B, Stewart JA, Nelson LA, Stewart WC.

Curr Eye Res. 2008 Feb;33(2):163-8.PMID: 18293187 [PubMed - indexed for MEDLINE]Related articles

A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.

Diestelhorst M, Larsson LI; European Latanoprost Fixed Combination Study Group.

Br J Ophthalmol. 2004 Feb;88(2):199-203.PMID: 14736774 [PubMed - indexed for MEDLINE]Related articlesFree article

A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.

Clin Ther. 2006 Mar;28(3):332-9.PMID: 16750448 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA; COSOPT versus XALATAN Study Groups.

Acta Ophthalmol Scand. 2004 Feb;82(1):42-8.PMID: 14982045 [PubMed - indexed for MEDLINE]Related articles

Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database.

Lazaridou MN, Montgomery DM, Ho WO, Jaberoo D.

Curr Med Res Opin. 2008 Oct;24(10):2725-8. Epub 2008 Aug 18.PMID: 18713491 [PubMed - indexed for MEDLINE]Related articles

Efficacy of the fixed combinations of bimatoprost or latanoprost plus timolol in patients uncontrolled with prostaglandin monotherapy: a multicenter, randomized, investigator-masked, clinical study.

Centofanti M, Oddone F, Vetrugno M, Manni G, Fogagnolo P, Tanga L, Ferreri P, Rossetti L.

Eur J Ophthalmol. 2009 Jan-Feb;19(1):66-71.PMID: 19123151 [PubMed - indexed for MEDLINE]Related articles

Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.

García Sanchez J.

Eur J Ophthalmol. 2000 Jul-Sep;10(3):198-204.PMID: 11071026 [PubMed - indexed for MEDLINE]Related articles

Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.

Petounis A, Mylopoulos N, Kandarakis A, Andreanos D, Dimitrakoulias N.

J Glaucoma. 2001 Aug;10(4):316-24.PMID: 11558817 [PubMed - indexed for MEDLINE]Related articles